Loading...

Alnylam Pharmaceuticals, Inc.

0HD2.L•LSE
Healthcare
Medical - Pharmaceuticals
£322.40
£0.04(0.01%)

Alnylam Pharmaceuticals, Inc. (0HD2.L) Stock Chart & Performance Analysis

Explore Alnylam Pharmaceuticals, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-7.42%
5-Day Change
-12.08%
1-Month Change
-6.97%
3-Month Change
-5.63%
6-Month Change
-19.89%
Year-to-Date (YTD) Change
-6.21%
1-Year Change
43.67%
3-Year Change
34.92%
5-Year Change
119.25%
All-Time (Max) Change
119.25%

Analyzing Alnylam Pharmaceuticals, Inc. (0HD2.L) Trends Across Multiple Time Frames

Alnylam Pharmaceuticals, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Alnylam Pharmaceuticals, Inc. stock shows -7.42% 1-day change, indicating low volatility, while its 5-day change of -12.08% suggests a broader trend. Over a 1-month period, a -6.97% drop could signal a pullback, whereas a 3-month decline of -5.63% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -19.89% and a YTD drop of -6.21% might concern investors, but a 1-year gain of 43.67% and a 3-year increase of 34.92% could indicate resilience. The 5-year surge of 119.25% highlights strong historical growth, while the all-time return of 119.25% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;